<p>Creative Biolabs is pleased to Dr. Bruce Walcheck to explore dual-function multi-engager antibodies targeting NK cells and tumor cells, revealing how TABK technology enhances cancer immunotherapy through innovative recombinant antibody approaches.</p>

Creative Biolabs is pleased to Dr. Bruce Walcheck to explore dual-function multi-engager antibodies targeting NK cells and tumor cells, revealing how TABK technology enhances cancer immunotherapy through innovative recombinant antibody approaches.

<p>Creative Biolabs is pleased to&nbsp;Dr. Bruce Walcheck to explore dual-function multi-engager antibodies targeting NK cells and tumor cells, revealing how TABK technology enhances cancer immunotherapy through innovative recombinant antibody approaches.</p>

Webinar: Generation of a Dual-Function Multi-Engager Antibody for Simultaneous Targeting NK Cells and Tumor Cells

Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.

Share Webinar: Generation of a Dual-Function Multi-Engager Antibody for Simultaneous Targeting NK Cells and Tumor Cells

Sign up to save your podcasts

Webinar: Generation of a Dual-Function Multi-Engager Antibody for Simultaneous Targeting NK Cells and Tumor Cells

Webinar: Generation of a Dual-Function Multi-Engager Antibody for Simultaneous Targeting NK Cells and Tumor Cells